Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 128   

Articles published

VRX 124.23 -0.39 (-0.31%)
price chart
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des ...
LAVAL, Quebec, July 24, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: ...
Valeant Files Another Complaint Over 'False' Allergan Info  Law360 (subscription)
Related articles »  
Valeant Pharmaceuticals Files Investor Presentation
LAVAL, Quebec, July 18, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) has filed an investor presentation with the Securities and Exchange Commission that will be used in meetings with Allergan's ...
Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition ...
LAVAL, Quebec, July 14, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has filed a premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S.
Valeant Pharma Files Premerger Notification Relating To Allergan Deal  NASDAQ
Related articles »  
Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
LAVAL, Quebec, July 10, 2014 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by ...
Related articles »  
TL Resistance Stocks in News- Juniper Networks, Inc. (NYSE:JNPR), Valeant ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) [Trend Analysis] reported on Monday that it has contacted regulators in the U.S.
Valeant Pharmaceuticals Intl Inc (TSE:VRX) Takeover Bid, Seems Expensive  Stixs News
Allergan restructuring to cut 1500 employees  China Post
Related articles »  
Valeant Pharmaceuticals Intl Now Covered by Deutsche Bank (VRX)
Valeant Pharmaceuticals Intl Inc logo Deutsche Bank initiated coverage on shares of Valeant Pharmaceuticals Intl (NYSE:VRX) in a research note released on Tuesday morning, TheFlyOnTheWall.
Correcting an earlier blog post �.  MarketWatch (blog)
Related articles »  
September 20th Options Now Available For Valeant Pharmaceuticals ...
Investors in Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options begin trading today, for the September 20th expiration.
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's ...  TheStreet.com
Related articles »  
September 5th Options Now Available For Valeant Pharmaceuticals ...
Investors in Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options begin trading today, for the September 5th expiration.
Related articles »  
Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology
LAVAL, Quebec, July 8, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. today announced it has completed the previously announced acquisition of PreCision Dermatology, Inc. PreCision develops and markets high quality dermatology ...
Valeant Pharmaceuticals Intl Short Interest Up 38.1% in June (VRX)  WKRB News
(PR) Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology  Wall Street Journal
Related articles »  
Drug Delivery: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Alkermes Plc ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that its wholly owned subsidiary, Bausch + Lomb has received 510(k) clearance from the U.S.
Related articles »